IndraLab

Statements

PD-153035 inhibits IKBKB. 1 / 1

| 1

reach

"Our data demonstrated that PD 153035 administration for 14 days prevents the activation of IKKbeta and JNK in liver, muscle, and WAT, which may be a consequence of the reduction in inflammation in WAT and in the circulating levels of FFAs, TNF-alpha, and IL-6."

19696185

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

PD-153035 inhibits IKBKB. 1 / 1

INDRA sources:

Databases

Reading